Resources
Featured MOC Resources
Clinical Patient Forms and Sample Documents
Treatment Agreements
Clinical Guides and Algorithms
- MOC Drug Testing and Ordering Reference
- Naloxone Step-by-Step
- SAMHSA Tip 63 Manual
- BMC OBAT Policy and Procedure Manual
- MAT in the ED
- Buprenorphine Induction (60 minute podcast)
- UCSF Guideline for the Perioperative Management for Buprenorphine
- MDHHS Opioid Start Talking
- Provider Protocol: Unsupervised Initiation for Fentanyl
- Patient Guide: Buprenorphine Initiation for Fentanyl
MOC Webinars
- Buprenorphine Management in Pain Patients Webinar (Video)
- Buprenorphine Management in Pain Patients Webinar (PDF)
- Benzodiazepines: The Hidden Epidemic
- Beyond the Waiver: Practical Tips for Buprenorphine Prescibers
- OUD and Pregnancy
- Addiction Treatment for Patients with Endocarditis: A Multidisciplinary Based Approach
- Methamphetamine 2020: New Risks, Current Treatments
- Neurobiology of Addiction
- Substance Use Disorder in Rural Communities
Substance Use Information
- Providers Clinical Support System (PCSS) Education & Training
- Providers Clinical Support System (PCSS) Webinars
- Providers Clinical Support System (PCSS) Substance Use Disorder 101
- American Society of Addiction Medicine (ASAM) Webinars
- UCSF Addiction Psychiatry Bootcamp
- Podcast- Core IM- #49 Smoking Cessation
- Podcast- Core IM- #19 Unhealthy Alcohol Use
- Podcast- Core IM- #27 Treatment for Alcohol Use Disorder
- Intersection of Pain and Addiction
Waiver Training and Support
Screening and Assessment Tools
Hepatitis C Resources
Research Articles and Books
- Next Stage in Burprenorphine Treatment (Addresses misconceptions about MAT)
- Interpreting Urine Drug Screen (UDS)
- Treating Opioid Addiction
- Monitoring Liver Function Tests in Patients Receiving Naltrexone or Extended Release Naltrexone
- A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World
- Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience
- Diversion of Methadone and Buprenorphine from Opioid Substitution Treatment: Patients who Regularly Sell or Share Their Medication
- Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma
- Perceptions and practices addressing diversion among US buprenorphine prescribers
- The relationship between diversion-related attitudes and sharing and selling buprenorphine
- Cost Effectiveness of Emergency Department-Initiated Treatment for Opioid Dependence
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
- Emergency department-based peer support for opioid use disorder: Emergent functions and forms
- Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
- Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program
- One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose
- A Financial Model for Team-Based Opioid Use Disorder Treatment
- INTEGRATING BEHAVIORAL HEALTH AND PRIMARY CARE: REIMBURSEMENT CONSIDERATIONS AND TIPS
- Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial
- Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder
- Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Review)
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009
- Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
- Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
- Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations
- Simultaneous quantification of buprenorphine, naloxone and phase Iand II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry
- Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study
- A buprenorphine education and training program for primary care residents: Implementation and evaluation
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers
- Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms
- Does Out Choice of Substance-Related Terms Influence Perceptions of Treatment Need? An Empirical Investigation with Two Commonly Used Terms
- Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation
- Caring for Ms. L. — Overcoming My Fear of Treating Opioid Use Disorder
- Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Other Websites and Organizations
- American Society of Addiction Medicine (ASAM)
- Boston Medical Center (BMC) Office Based Addiction Treatment (OBAT)
- Provider Clinical Support System (PCSS)
- American Association for the Treatment of Opioid Dependence, Inc. (AATOD)
- Harm Reduction Approach to Treatment of All Substance Use Disorders
- Prescribe to Prevent (Naloxone)